Juan Luis Alcala-Zermeno

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Chronic Kidney Disease

End Stage Renal Disease

Ejection Fraction

Top Venues

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Juan Luis Alcala-Zermeno, Brandy E Fureman, Caitlin L Grzeskowiak, Ojas Potnis, Maria Taveras, Margaret W Logan, Delanie Rybacki, Daniel Friedman, Daniel H Lowenstein, Ruben Kuzniecky, Jacqueline A French, null null
Racial disparities in the utilization of invasive neuromodulation devices for the treatment of drug-resistant focal epilepsy. Epilepsia (2024)
Juan Luis Alcala-Zermeno, Brandy E Fureman, Caitlin L Grzeskowiak, Ojas Potnis, Maria Taveras, Margaret W Logan, Delanie Rybacki, Daniel Friedman, Daniel H Lowenstein, Ruben Kuzniecky, Jacqueline A French, null null
Racial disparities in the utilization of invasive neuromodulation devices for the treatment of drug-resistant focal epilepsy. Epilepsia 65 (5) (2024)
Juan Luis Alcala-Zermeno, Brandy E Fureman, Caitlin L Grzeskowiak, Ojas Potnis, Maria Taveras, Margaret W Logan, Delanie Rybacki, Daniel Friedman, Daniel H Lowenstein, Ruben Kuzniecky, Jacqueline A French, null null
Racial disparities in the utilization of invasive neuromodulation devices for the treatment of drug-resistant focal epilepsy. Epilepsia 65 (5) (2024)
Sarah Clark, Juan Luis Alcala-Zermeno
Apixaban anti-Xa levels in clinical practice: A case report. British journal of clinical pharmacology (2024)
Levente Hadady, Mickael R Sperling, Juan Luis Alcala-Zermeno, Jacqueline A French, Patricia Dugan, Lara E Jehi, Daniel Fabo, Péter Klivényi, Guido Rubboli, Sándor Beniczky
Prediction tools and risk stratification in epilepsy surgery. Epilepsia (2023)
Juan Luis Alcala-Zermeno, Keith Starnes, Nicholas M Gregg, Greg Worrell, Brian Nils Lundstrom
Responsive neurostimulation with low-frequency stimulation. Epilepsia (2022)